A detailed history of Artisan Partners Limited Partnership transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 550,273 shares of VRTX stock, worth $248 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
550,273
Previous 515,386 6.77%
Holding current value
$248 Million
Previous $242 Million 5.94%
% of portfolio
0.4%
Previous 0.38%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$460.0 - $505.78 $16 Million - $17.6 Million
34,887 Added 6.77%
550,273 $256 Million
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $14.7 Million - $18.2 Million
-37,496 Reduced 6.78%
515,386 $242 Million
Q1 2024

May 13, 2024

SELL
$407.69 - $446.08 $9.63 Million - $10.5 Million
-23,625 Reduced 4.1%
552,882 $231 Million
Q4 2023

Feb 12, 2024

SELL
$343.0 - $410.68 $3.2 Million - $3.83 Million
-9,334 Reduced 1.59%
576,507 $235 Million
Q3 2023

Nov 09, 2023

SELL
$338.18 - $362.46 $18.2 Million - $19.6 Million
-53,955 Reduced 8.43%
585,841 $204 Million
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $553,064 - $619,009
-1,759 Reduced 0.27%
639,796 $225 Million
Q1 2023

May 11, 2023

BUY
$283.23 - $323.1 $128 Million - $146 Million
453,085 Added 240.4%
641,555 $202 Million
Q4 2022

Feb 10, 2023

SELL
$285.76 - $321.48 $11.2 Million - $12.6 Million
-39,234 Reduced 17.23%
188,470 $54.4 Million
Q3 2022

Nov 10, 2022

SELL
$273.83 - $305.53 $41.3 Million - $46.1 Million
-150,876 Reduced 39.85%
227,704 $65.9 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $22.5 Million - $28 Million
-95,813 Reduced 20.2%
378,580 $107 Million
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $2.67 Million - $3.15 Million
12,079 Added 2.61%
474,393 $124 Million
Q4 2021

Feb 11, 2022

SELL
$177.01 - $223.45 $480,936 - $607,113
-2,717 Reduced 0.58%
462,314 $102 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $195,538 - $218,823
-1,078 Reduced 0.23%
465,031 $84.4 Million
Q2 2021

Aug 12, 2021

BUY
$187.49 - $221.1 $87.4 Million - $103 Million
466,109 New
466,109 $94 Million
Q4 2020

Feb 10, 2021

SELL
$207.01 - $276.09 $9.44 Million - $12.6 Million
-45,582 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$255.65 - $303.1 $11.7 Million - $13.8 Million
45,582 New
45,582 $12.4 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.